Equities
IndustrialsGeneral Industrials
  • Price (SEK)60.45
  • Today's Change0.80 / 1.34%
  • Shares traded146.00k
  • 1 Year change-29.71%
  • Beta1.1439
Data delayed at least 15 minutes, as of May 25 2022 12:30 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Nolato AB is a Sweden-based company engaged in the development and manufacture of polymer product systems for customers in medical technology, pharmaceuticals, consumer electronics, telecom, automotive products, hygiene and other industrial sectors. The Company’s operations are divided into three operating segments. The Medical Solutions segment develops and manufactures complex product systems and components for medical devices, the pharmaceutical industry and diagnostics. The Integrated Solutions segments offers a wide range of technologies and expertise in a one-stop shop for areas including injection molding, casting, die-cutting, painting, decoration, assembly, testing and packaging of electronic products. The Industrial Solutionssegment develops and manufactures components and product systems for customers in the automotive industry, hygiene, packaging, gardening/ forestry, domestic appliances, furniture and other selected industrial segments. The Company operates worldwide.

  • Revenue in SEK (TTM)11.84bn
  • Net income in SEK1.14bn
  • Incorporated--
  • Employees7.38k
  • Location
    Nolato ABNolatovagen 32, Torekov 269 78SwedenSWE
  • Phone+46 431442290
  • Fax+46 431442291
  • Websitehttps://www.nolato.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aquafil SpA5.97bn111.78m3.01bn2.76k32.012.265.870.50360.20930.209311.152.970.845-1.1221.40--1.582.602.233.68132.1753.971.872.860.88674.420.686133.8830.493.401,693.28-11.835.28--
Crete Plastics SA3.93bn554.26m4.45bn1.13k8.021.256.531.131.931.9313.6912.380.94953.654.97332,325.3013.9711.9816.5314.7225.7725.3914.7112.933.51--0.0282--23.056.4214.3715.0527.09--
Gurit Holding AG4.75bn115.42m5.33bn2.45k46.122.7523.431.122.432.43100.0840.731.324.705.35190,991.802.589.714.0415.0418.1721.491.966.961.3011.630.283223.97-19.165.86-75.79-15.2817.92-18.94
SIMONA AG5.70bn387.83m5.34bn1.55k13.111.999.250.93666.496.4995.5342.651.132.997.86351,542.307.595.868.856.6643.4746.606.705.612.0733.760.057531.9139.718.2360.0613.709.667.21
SP Group A/S3.49bn285.52m6.12bn2.38k21.223.9212.171.7516.4016.40200.6488.771.033.227.281,042,382.008.488.4212.6013.1128.3327.008.197.480.511924.730.454317.9513.9010.3134.4417.0113.4520.11
Aksa Akrilik Kimya Sanayii AS6.64bn1.01bn9.72bn1.36k9.664.678.811.465.135.1333.8110.601.467.5110.458,181,625.0022.1610.5942.9220.4924.2220.5915.1610.730.80584.600.505763.33103.1333.70165.3056.1341.2826.49
Nolato AB11.84bn1.14bn14.42bn7.38k14.152.918.901.224.214.2143.9820.491.248.988.131,366,248.0011.8412.5017.2918.7615.2115.809.589.071.23--0.0051.0224.0521.1643.9228.1228.5212.59
KuybyshevAzot PAO14.72bn3.54bn16.69bn--3.541.50--1.13118.91118.91493.66280.601.086.2520.47--26.2010.5333.1013.0538.6628.4024.1811.171.12--0.283324.0464.8815.532,833.2930.32-10.4555.64
Synthomer PLC28.49bn2.55bn17.69bn4.63k6.341.424.560.62110.48830.48835.372.181.03--8.10502,914.509.316.2312.178.59--22.599.015.531.4621.030.390961.4241.6817.376,632.2613.5812.5123.25
Victrex plc3.93bn859.63m18.09bn895.0021.123.1616.054.600.80530.80533.685.390.56091.905.84359,329.6012.1715.7213.3617.2652.5259.1821.7029.022.04104.670.049786.0217.664.2935.06-2.3610.104.93
Organicheskiy Sintez Kazan PAO14.18bn3.20bn20.92bn8.26k6.481.665.571.4810.6610.6647.2241.561.056.2156.49--23.6721.3626.9624.2336.6435.2022.5720.271.72107.580.011960.96-13.29-1.74-29.11-14.718.670.8167
Data as of May 25 2022. Currency figures normalised to Nolato AB's reporting currency: Swedish Krona SEK

Institutional shareholders

32.97%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 31 Mar 202219.16m7.92%
Lannebo Fonder ABas of 31 Oct 202117.83m7.37%
F�rsta AP-fondenas of 13 May 202213.55m5.61%
Didner & Gerge Fonder ABas of 31 Oct 20216.28m2.60%
The Vanguard Group, Inc.as of 05 May 20224.83m2.00%
Swedbank Robur Fonder ABas of 31 Oct 20214.12m1.70%
Norges Bank Investment Managementas of 31 Oct 20213.80m1.57%
Dimensional Fund Advisors LPas of 05 May 20223.49m1.45%
Montanaro Asset Management Ltd.as of 31 Oct 20213.47m1.44%
Lupus alpha Asset Management AGas of 31 Oct 20213.18m1.32%
More ▼
Data from 31 Aug 2021 - 29 Apr 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.